Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Opt Lett ; 34(11): 1645-7, 2009 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-19488135

RESUMO

We describe chalcogenide glass (ChG)-based nanostructures for use as substrates for surface-enhanced Raman scattering (SERS). Such substrates were fabricated by exploiting the photosensitivity of ChG. This allows convenient control of the shape, size, and spacing of the nanostructures. The substrates were used to investigate the sample-concentration and excitation-power dependences of SERS from Rhodamine 6G molecules. A sensitivity of 1 muM was achieved at low excitation irradiance, and a semilinear concentration dependence was found for concentrations below 100 muM, demonstrating the potential of these ChG-based SERS substrates for high-sensitivity quantitative analysis.

3.
BMJ ; 299(6707): 1083-6, 1989 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-2511973

RESUMO

OBJECTIVE: To audit the first five years of a colposcopy and treatment service for cervical dysplasia established within a general practice. DESIGN: A cervical smear register was established to determine which women were "at risk" of dysplasia. The results of colposcopy and treatment of dysplasia were analysed. SETTING: A large rural general practice with community hospital facilities in mid-Wales. PATIENTS: 4437 Women at risk in a total practice population of 14,100. INTERVENTIONS: Colposcopy of women with dyskaryotic smear results, persistent inflammatory smear results, or vulval warts. Treatment of women with proved dysplasia by electrodiathermy of the cervix or cone biopsy. RESULTS: 138 Women with dysplasia were diagnosed over five years: 36 mild, 97 moderate or severe, and five with microinvasion. Despite a 78% smear rate of at risk women over five years, nine invasive cancers still occurred. CONCLUSIONS: The results of treatment are acceptable. Cervical dysplasia has become very common, the risk of a dysplasia in women aged 20-39 who had smear tests being one in 14 over five years.


Assuntos
Neoplasias do Colo do Útero/diagnóstico , Adolescente , Adulto , Fatores Etários , Idoso , Colposcopia , Medicina de Família e Comunidade , Feminino , Humanos , Pessoa de Meia-Idade , Prognóstico , Fatores de Risco , População Rural , Displasia do Colo do Útero/diagnóstico , Displasia do Colo do Útero/terapia , Neoplasias do Colo do Útero/terapia , Esfregaço Vaginal , País de Gales
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...